Gerry Brunk is listed as a director on 3 SEC Form D filings by 1 issuer between May 2023 and Sep 2024: Navion Neurosciences Inc. (Charlottesville, VA — other health care — 2023–2024; $4.96M reported sold to 8 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Andrew J. Krouse (3 shared filings), Marianne Bjordal (3 shared filings) and Kurt Woerpel (1 shared filing).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Gerry. Each name links to their own page.
The issuer belongs to the sponsor group Slate (2 issuers, $4.73M reported sold, 2021–2026).
What this means A sponsor group is one team that sets up a new company for each deal. Slate has 2 companies on file and $4.73M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 3 public filings for Gerry Brunk and found 7 differences: No amendment in the last 12 months on an offering that may still be open; Offering amount changed between filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.